Clinical Trial

Total Arterial vs. Mixed Grafting in Left Coronary CABG

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, double-blind controlled trial comparing the clinical efficacy of total arterial grafting (internal thoracic artery and radial artery) versus conventional mixed grafting (internal thoracic artery and great saphenous vein) in the left coronary artery system during coronary artery bypass grafting (CABG). A total of 400 patients undergoing elective CABG at the Second Hospital of Jilin University will be enrolled and randomized into two groups. The primary endpoint is graft patency at 12 months postoperatively, evaluated by coronary angiography or CT angiography. Secondary outcomes include perioperative complications, major adverse cardiovascular events (MACE), and long-term clinical prognosis. The study aims to provide evidence-based guidance on optimal graft selection in CABG.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-09.
Trial Details
NCT Number NCT07057713
Lead Sponsor Second Hospital of Jilin University
Conditions Coronary Artery Disease, Coronary Artery Bypass Grafting, Arterial Graft, Graft Patency, Major Adverse Cardiovascular Events
Enrollment 400 participants
Start Date 2026-08-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23